You just read:

Asia-Pacific Non-Small Cell Lung Cancer Therapeutics Markets to 2023: Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market - Research and Markets

News provided by

Research and Markets

07 Apr, 2017, 15:30 ET